UCB

Corporation with Board of Directors
Brussels, Belgium
Closing date: December 31
Date of the Last Annual General Meeting: April 29 2021
- BEL 20 ,
- STOXX®Europe 600 ,
- Eurozone 300
- E&B Pharmaceuticals & Biotechnology

Governance leadership structure

Board of Directors

Stefan OSCHMANN
Chair
Since 7 months

Other directorships

14 voting members without any non-voting

Independents
Executives
Employees representatives
State representatives
Other

Directors
average seniority 5 years
5.1 years for elected by shareholders

Directors
average age - years
- years for elected by shareholders

Chair and CEO roles are separated:
Majority of independent members in the Audit Committee?	Yes
Majority of independent members in the Remuneration Committee?	Yes

Jean-Christophe TELLIER
Chief Executive Officer
Since almost 7 years
Other directorships

57.8 % Percentage of variable remunerations in 2020 Global compensation

Board & Leadership

Board of Directors

Your Internet Explorer version is outdated. Upgrade it, or download Google Chrome for a better experience.